Brazil Minimally Invasive Surgery Devices Market Industry Is Estimated to Grow at A CAGR 8.6% by 2023 | Leaders Analysis by Abbott Laboratories, Boston Scientific Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz GmbH & Co. KG, Medtronic, Nov

Brazil minimally invasive surgery devices market was valued at USD 905.28 million in 2016. It is projected to reach USD 1366.3 million by 2022, at a CAGR of 8.6% over the forecast period. Mexico and Brazil have, collectively, occupied more than 50% of the total Latin American minimally invasive surgery market.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16700
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Increasing Number of Surgeries among the Aging Population
There are numerous imaging technologies and new devices that are being used for the heart and other chronic diseases surgeries, and these surgeries are being performed using the minimally invasive devices and equipment. Minimally invasive procedures also provide better quality of life and with less medical restrictions and associated risks. According to a study, there are around 211 million people in Brazil, out of which, 17.724 million are above 65 and 2.34 million are 80 years and above. The growing prevalence of cardiac diseases, especially among the elderly, has increased the adoption of minimally invasive procedures in Brazil.
However, the growing GDP of the region has resulted in growth in the disposable income, which will drive the minimally invasive surgery market in the future. It is also expected that the growth of geriatric population in Latin America, as healthcare services become affordable and effective, will also drive the minimally invasive surgery market.

Key Developments in the Market
March, 2017: Boston Scientific had announced an agreement to acquire Symetis, which will expand treatments for patients with Valvular heart disease and strengthen the company's position in structural heart, globally.
January, 2017: Johnson & Johnson and Actelion Ltd hosted a conference call for investors to announce that they have entered into a definitive agreement for Johnson & Johnson to acquire Actelion Ltd for USD 30 billion, with a spin out of a new R&D company.
January, 2017: Ethicon Endo-Surgery, Inc. (Subsidiary of Johnson & Johnson) announced that it had acquired Megadyne Medical Products, Inc., a privately held medical device company that develops, manufactures, and markets electrosurgical tools used in operating rooms, worldwide.

Major Players:
Abbott Laboratories, Boston Scientific Corporation, Intuitive Surgical Inc., Johnson & Johnson, Karl Storz GmbH & Co. KG, Medtronic, Novatract Surgical Inc., Smith & Nephew PLC, Stryker Corporation, Zimmer Inc. amongst others.

Request Discount on this report @https://marketprognosis.com/discount-request/16700
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Costly Minimally Invasive Surgery Procedures
Minimally invasive procedures are less adopted in Brazil as they are costly. The low- and middle-class people cannot bear the high expenses, which is posing a challenge to improve the quality of treatment through advanced minimally invasive procedures. Robotic surgeries involved in cardiac problems and spinal fusion are some of the high-end minimally invasive treatments, which require high amount of capital. The advanced laparoscopic and endoscopic approaches leads to increased cost of instrumentation and higher operating costs. Therefore, due to the high costs of these procedures, only 50 hospitals in Brazil are currently providing the minimally invasive treatments. Owing to these factors, minimally invasive surgery procedures are facing challenges in Brazil. The shortage of proper skilled labor and stringent regulatory frameworks are also the major challenges faced by the minimally invasive device market.

Brazil to Report Fastest Growth in the Minimally Invasive Surgery Devices Market
Mexico and Brazil, collectively, occupied more than 50% of the total Latin American minimally invasive surgery market in 2013. In addition, during the period of 2014 to 2020, Mexico is expected to show the fastest growth in the minimally invasive surgery market across Latin America. However, the Brazil market is not to be left behind. According to the International Society of Aesthetic Plastic Surgery, Brazil surpassed the US in 2013 in the number of cosmetic surgeries performed in the country, annually; between 2009 and 2012, the number of plastic surgery procedures rose by 120% in Brazil.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/16700
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No:+1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.